Sponsor or institution

Clinical trials and research at Tongji Hospital

• 160Clinical trials
• 3New in 30 days
• 1Country

Newest trials

All recruiting trials (newest 150 of 160)

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Zhixuan Analgesic Tablet for frequent tension-type headaches

  A randomized trial tests whether Zhixuan Analgesic Tablet, taken three times daily for 12 weeks, can reduce headache days in adults with frequent episodic tension-type headaches compared with a placebo.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT07872943

• Rimegepant for acute vestibular migraine in adults

  This study tests whether a first dose of rimegepant followed by a second dose of placebo, or first dose placebo followed by a second dose of rimegepant, helps relieve acute vestibular symptoms in adults with vestibular migraine.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT07871097

• Cardiorespiratory fitness after lobectomy versus sublobar resection in NSCLC

  This study tests how different lung surgeries (lobectomy vs. sublobar resection) affect fitness levels after surgery in people with non-small cell lung cancer.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07841249

• MRI plus diffusion and CEST imaging to map liver cancer and its immune environment

  This study tests whether adding an extra MRI sequence can help see how the liver cancer microenvironment changes and relate those changes to immune activity in patients with hepatocellular carcinoma.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07838415

• Postoperative EGFR-TKI Therapy for EGFR-mutant NSCLC Following Surgery

  This registry tests whether giving an EGFR-TKI after surgery helps adults with EGFR-mutant, high-risk early-stage NSCLC.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07837739

• Terfenadine added to standard MS therapy in relapsing MS

  This study tests whether adding terfenadine to usual MS treatment is safe and may help reduce disease activity in adults with relapsing-remitting MS.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT07827716

• Umbilical Cord Mesenchymal Stem Cells for Diabetic Kidney Disease

  This study tests whether injecting human umbilical cord mesenchymal stem cells can help people with diabetic nephropathy by reducing kidney inflammation and damage.

  Recruiting Phase 1 Tongji Hospital · Wuhan · NCT07822152

• Effects of Fospropofol Disodium TIVA and IVIH on Surgical Field Quality in Adult ESS

  This study tests fospropofol disodium–based anesthesia options to see which provides the clearest surgical field during endoscopic sinus surgery in adults.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07788157

• Trastuzumab Rezetecan and Gemcitabine before surgery for HER2-positive UTUC

  This study tests whether giving trastuzumab deruxtecan with gemcitabine before and around surgery can improve outcomes for people with HER2-positive upper tract urothelial cancer.

  Recruiting at 10 sites Phase 2 Tongji Hospital · Huanggang, Hubei and 9 other locations · NCT07741448

• Neoadjuvant Cardonilizumab With Chemotherapy Before Surgery for Locally Advanced Esophageal Squamous Cell Carcinoma

  This study tests whether adding cardonilizumab to preoperative chemotherapy (versus chemoradiotherapy) helps patients with locally advanced ESCC have a better chance at complete tumor removal and longer survival.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT07699185

• Neoadjuvant RC48 plus gemcitabine vs RC48 plus toripalimab for muscle-invasive bladder cancer

  This trial tests whether RC48 with gemcitabine works as well as RC48 with toripalimab as a pre-surgery treatment for muscle-invasive bladder cancer in adults.

  Recruiting at 22 sites Phase 3 Tongji Hospital · Hefei, Anhui and 21 other locations · NCT07693959

• Wearable device for early warning of postoperative complications after thoracic surgery

  A wearable device is used to see if continuous monitoring can spot early signs of problems after thoracic surgery in adults.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07646730

• Rice-derived albumin for low albumin after liver surgery

  This study tests rice-derived recombinant human serum albumin (OsrHSA) to correct low albumin in adults after liver resection.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT07634549

• Jinfeng Pill for perimenopausal syndrome in women aged 45–55

  A randomized, double-blind study will test whether the Jinfeng Pill can help relieve perimenopausal symptoms compared with a placebo.

  Recruiting at 3 sites Phase 4 Tongji Hospital · Wuhan, Hubei and 2 other locations · NCT07606755

• Somatostatin with a clear liquid diet vs a diverting stoma after low rectal cancer surgery

  Doctors will test whether giving somatostatin plus a clear liquid diet after ultra-low anterior resection can prevent severe leakage as well as a protective diverting stoma in adults with low or mid rectal cancer.

  Recruiting at 2 sites Tongji Hospital · Ezhou, Hubei and 2 other locations · NCT07605611

• Minocycline after successful recanalization in acute anterior circulation stroke

  This trial tests whether adding minocycline after a successful endovascular thrombectomy helps people recover better after an acute anterior circulation stroke.

  Recruiting Phase 2/3 Tongji Hospital · Wuhan, Hubei · NCT07594314

• Minocycline after successful reopening of posterior circulation stroke with endovascular therapy

  This trial tests whether adding minocycline after successful thrombectomy helps people recover better from a posterior circulation stroke.

  Recruiting Phase 2/3 Tongji Hospital · Wuhan, Hubei · NCT07594301

• Liver Cancer Care: Tracking Real-World Diagnoses and Treatments at Tongji Hospital

  This study blindly follows adults with liver cancer at Tongji Hospital to see how different treatments work in real-world care over time.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07587216

• QH103 (universal CD19 CAR-γδT) cell injections for relapsed or treatment‑resistant antibody-driven neurological autoimmune diseases

  This Phase 1 test will see if QH103 (universal CD19 CAR-γδT) cell injections are safe and tolerated in adults with relapsed or treatment‑resistant antibody-mediated neurological diseases such as MS, NMOSD, AE, CIDP, or MG.

  Recruiting Phase 1 Tongji Hospital · Wuhan, Hubei · NCT07526493

• Comparing manual and electroacupuncture for functional constipation

  This trial will try manual acupuncture and electroacupuncture to see which produces more complete spontaneous bowel movements in adults with functional constipation.

  Recruiting Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT07506122

• SHR-1701 with short-course radiotherapy and CAPOX before surgery for locally advanced rectal cancer

  This will test whether adding the drug SHR-1701 to short-course radiotherapy plus CAPOX before surgery helps people with locally advanced rectal cancer.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT07478731

• How PEG bowel preparation affects gut bacteria in people with or without an appendix

  This observational study will test whether polyethylene glycol colonoscopy prep changes gut bacteria differently in adults who have had an appendectomy compared with those who have not.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07478029

• AI for precise MRI diagnosis of cranial conditions

  This project will test whether an AI system can read cranial MRI scans and help doctors diagnose brain tumors, stroke, and other cranial diseases more accurately and consistently.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07446842

• PEG bowel preparation effects on gut microbes after gallbladder removal

  This study tests whether PEG-based colonoscopy prep causes larger or longer-lasting changes to gut microbes in adults who have had their gallbladder removed compared with people who still have their gallbladder.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07439640

• Lenvatinib plus PD-1 inhibitor for tumors with 11q13 amplification

  This trial tests whether combining lenvatinib with a PD-1 inhibitor can help adults with advanced solid tumors that have 11q13 gene amplification.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT07417501

• Tislelizumab plus Huaier granule as first treatment for unresectable liver cancer

  This tests whether giving tislelizumab together with Huaier granule as a first treatment helps people with unresectable hepatocellular carcinoma.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT07413354

• AI-based prediction of liver metastasis after colorectal cancer surgery

  This project will try a deep learning model that combines CT scans, digitized pathology slides, and routine clinical data to predict which stage I–III colorectal cancer patients are likely to develop liver metastases after curative surgery.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07399236

• AI model to predict risk of liver spread after colorectal cancer surgery

  This project will test whether an AI model using preoperative CT scans, postoperative pathology images, and routine clinical data can predict the risk of liver metastasis within two years for people having curative surgery for stage I–III colorectal cancer.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07392567

• Adebrelimab plus gemcitabine, cisplatin, and simvastatin for advanced biliary tract cancer

  This trial tests whether adding adebrelimab and simvastatin to standard gemcitabine–cisplatin chemotherapy helps people with advanced biliary tract cancer.

  Recruiting Phase 1/2 Tongji Hospital · Wuhan, Hubei · NCT07392541

• Acupuncture plus mesalazine for ulcerative colitis

  This trial tests whether adding acupuncture with intradermal thumbtack needles to standard mesalazine helps people with active ulcerative colitis feel better.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07389824

• Predicting outcomes of pre-surgery treatment for non-small cell lung cancer

  This project will try to use clinical, imaging, and molecular data to predict which patients with non-small cell lung cancer will respond to neoadjuvant chemo‑immunotherapy before surgery.

  Recruiting at 2 sites Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT07388771

• Tegileridine plus intercostal nerve block for pain after thoracoscopic lung removal

  This trial will test whether giving a local intercostal nerve block together with patient-controlled tegileridine improves pain control for adults having thoracoscopic lobectomy or segmentectomy.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07386626

• KD01 delivered directly into the bladder for bladder cancer

  This Phase I test gives KD01—an oncolytic adenovirus—directly into the bladder to see if it is safe and shows early benefit for adults with high‑risk non‑muscle‑invasive disease or certain muscle‑invasive bladder cancers.

  Recruiting Phase 1 Tongji Hospital · Wuhan, Hubei · NCT07359235

• Using AI on scans, pathology, and genetics to predict treatment response and risk in esophageal cancer

  This project uses AI that combines CT scans, pathology images, and genetic data to try to predict how people with esophageal cancer will respond to treatment and what their prognosis may be.

  Recruiting Tongji Hospital · Wuhan, Other (Non U.s.) · NCT07354295

• Testing a four-drug regimen (methotrexate, rituximab, sintilimab, pirtobrutinib) versus investigator-selected care for newly diagnosed PCNSL

  This trial will try a combination of methotrexate, rituximab, sintilimab and pirtobrutinib as first treatment for adults with newly diagnosed primary central nervous system lymphoma to see if it increases complete remissions and is safe compared with standard doctor-selected treatments.

  Recruiting at 3 sites Phase 2 Tongji Hospital · Xiamen, Fujian and 3 other locations · NCT07350850

• CAR-T therapy targeting CD19 and BCMA to desensitize highly sensitized kidney transplant candidates

  This will test whether AZD0120, a dual CD19/BCMA CAR-T cell therapy, can safely reduce donor-specific antibodies and enable kidney transplant in highly sensitized adults with end-stage kidney disease.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT07350837

• BAFFR CAR-T therapy for relapsed or treatment-resistant B‑cell cancers

  This study will try BAFFR-directed CAR-T cell therapy in adults whose B‑cell cancers have come back or not responded to prior treatments to see if it is safe and works.

  Recruiting Tongji Hospital · Wuhan · NCT07345728

• CD19/BCMA-targeted UCAR-T for neurological autoimmune disorders

  This trial tests an off-the-shelf CD19/BCMA UCAR-T cell therapy with lymphodepletion in adults with relapsing or treatment-resistant MS, myasthenia gravis, CIDP, or autoimmune encephalitis.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT07337785

• Non-contrast MRI tracking of kidney transplant function using donor baselines

  This study will test whether non-contrast MRI scans can track kidney transplant health over time by using donor scans as personalized baselines and by applying the technique to recipients without donor data, for adults who have had or will receive a kidney transplant.

  Recruiting Tongji Hospital · Shiyan, Hubei and 2 other locations · NCT07333495

• Celiac plexus block plus first-line systemic therapy for advanced biliopancreatic cancer with pain

  This study will try giving a celiac plexus block alongside standard first-line cancer drugs to see if it reduces pain and helps people with advanced bile duct or pancreatic cancer.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07326137

• Emotional distress and immunotherapy response in liver cancer

  This project will see if emotional distress changes how well immunotherapy works for people with newly diagnosed, treatment‑naïve liver cancer.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07325565

• GC012F CAR-T tolerability and safety for people with multiple sclerosis

  This early-phase test will try a single infusion of GC012F CAR-T cells in adults with multiple sclerosis to see if it is tolerable and safe.

  Recruiting Early Phase 1 Tongji Hospital · Hubei, Hubei · NCT07303790

• Intra-arterial tenecteplase for medium-vessel occlusion stroke

  This trial will test whether delivering tenecteplase directly into the blocked medium brain artery helps adults with medium-vessel ischemic stroke recover better when treated within 24 hours of symptom onset.

  Recruiting Phase 2/3 Tongji Hospital · Wuhan, Hubei · NCT07302854

• AI-guided personalized pre- and post-surgery treatment to reduce liver cancer recurrence

  This will try using an AI tool to pick early-stage hepatocellular carcinoma patients at high risk of recurrence and give them medication before and after surgery to see if it reduces the chance the cancer comes back within two years.

  Recruiting Phase 1/2 Tongji Hospital · Wuhan, Hubei · NCT07282184

• Headache registration and follow-up program at Tongji Hospital

  This program will collect clinical records, imaging, questionnaires, and blood samples from people aged 6–70 with diagnosed headaches to build a large database to help develop better diagnosis and treatments.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07269561

• Flu vaccine after a heart attack or unstable angina

  This trial will test whether giving a flu shot to adults aged 18–80 who recently had acute coronary syndrome lowers the chance of future heart attacks, stroke, or death.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07259252

• Full-house endoscopic sinus surgery with or without nasopharyngeal lymphoid tissue ablation for nasal polyps

  This study will test whether adding nasopharyngeal lymphoid tissue ablation to full-house endoscopic sinus surgery helps adults with nasal polyps have less nasal inflammation and fewer recurrences.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07245329

• Donor γδ T cell infusion to prevent relapse after stem cell transplant in high‑risk AML

  This will test whether a donor γδ T cell infusion given soon after an allogeneic stem cell transplant can help prevent relapse in adults (18–65) with high‑risk acute myeloid leukemia.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07237230

• Using a paravertebral block during thoracic (VATS/RATS) surgery to reduce postoperative complications

  This study will try an intraoperative paravertebral block to see if it lowers postoperative complications in adults having VATS or RATS for lung or mediastinal procedures.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07211529

• Stereotactic tenecteplase clot liquefaction for supratentorial intracerebral hemorrhage

  This trial will see if stereotactic minimally invasive clot drainage plus a single low dose of tenecteplase helps adults with moderate-to-large supratentorial intracerebral hemorrhage recover better than standard medical care.

  Recruiting at 51 sites Tongji Hospital · Anqing, Anhui and 50 other locations · NCT07208097

• Xiqing plus probiotics to improve gut balance and drug effects in chronic kidney disease

  This trial will test whether adding Xiqing and probiotics helps lower nitrogen waste and improve drug effectiveness in adults with stage 3–5 chronic kidney disease who are not on dialysis.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT07182942

• Apatinib and camrelizumab plus TACE before liver resection for centrally-located BCLC‑B hepatocellular carcinoma

  This trial tests whether giving apatinib and camrelizumab together with TACE before planned liver surgery can shrink tumors and improve outcomes for adults with centrally-located BCLC stage B hepatocellular carcinoma who are eligible for resection.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT07154082

• New MRI methods to measure metabolism and predict outcomes in metabolic-associated fatty liver disease

  This project tests whether new MRI techniques can measure body metabolism and help predict disease status and prognosis for people with metabolic-associated fatty liver disease.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07149571

• Adebrelimab with apatinib plus gemcitabine–cisplatin for initially unresectable biliary tract cancer

  This trial tests whether adding the immunotherapy adebrelimab and the targeted drug apatinib to standard chemotherapy helps people with newly diagnosed, unresectable biliary tract cancer.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT07135544

• Weekly electronic symptom tracking during definitive chemoradiotherapy for lung cancer

  This project will test whether weekly electronic questionnaires can map symptom severity and clusters in adults with unresectable stage III non-small cell or limited-stage small cell lung cancer receiving definitive concurrent chemoradiotherapy.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07131670

• AI-driven multimodal tool to identify early cognitive problems in people with type 2 diabetes

  This project will test whether an AI-based multimodal screening system can find early memory problems in people aged 40–75 with type 2 diabetes during a 3–5 year follow-up.

  Recruiting at 15 sites Tongji Hospital · Enshi, Hubei and 20 other locations · NCT07128186

• Comparing remimazolam and ciprofol anesthesia to reduce breathing problems in children having tonsil and adenoid surgery.

  This trial tests whether remimazolam or ciprofol given as total intravenous anesthesia (TIVA) better prevents breathing problems during and after tonsil and adenoid removal in children aged 2–12.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT07118579

• Using AI on CT scans to predict complete response in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy

  This project will test whether a deep-learning model using chest CT images and clinical data can predict which esophageal squamous cell carcinoma patients will have a complete pathological response after neoadjuvant immunochemotherapy.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07088354

• GC012F CAR-T therapy for refractory idiopathic inflammatory myopathy

  This trial will test GC012F, a CAR-T cell therapy, in adults with idiopathic inflammatory myopathy that has not improved with standard treatments.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT07086404

• Telitacicept versus cyclophosphamide for lupus-related interstitial lung disease

  This trial will test whether telitacicept works better than cyclophosphamide to treat early interstitial lung disease in adults with lupus.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT07077486

• Real-world comparison of drugs used to treat Familial Mediterranean Fever

  We will look at medical records to see if different drugs control symptoms and are safe for people with Familial Mediterranean Fever.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07077473

• Jianmin Daopeng Angong Niuhuang Wan to help recovery after traumatic brain injury

  This tests whether Jianmin Daopeng Angong Niuhuang Wan (with lab-grown cow bile) helps adults who recently had a traumatic brain injury regain consciousness and neurological function.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07074938

• iPSC-derived exosome treatment for Moyamoya disease

  This Phase 1 trial will test whether applying iPSC-derived extracellular vesicles to the temporal muscle can help adults with Moyamoya disease who had a temporal muscle patch but still have inadequate blood flow.

  Recruiting Phase 1 Tongji Hospital · Wuhan, Hubei · NCT07065409

• AI prediction of liver cancer returning after surgery

  This study will test whether an AI program can identify people with early-stage liver cancer who are likely to have the cancer come back within two years after surgery.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07062380

• GC012F CAR‑T infusion for refractory generalized myasthenia gravis

  This trial tests a one-time GC012F CAR‑T cell infusion to see if it helps adults (18–75) with refractory generalized myasthenia gravis who have not responded to standard treatments.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT07058298

• Durvalumab consolidation after chemoradiotherapy for limited-stage small cell lung cancer

  This trial tests whether giving durvalumab alongside and after standard chemoradiotherapy helps people with limited-stage small cell lung cancer have better tumor control and longer survival.

  Recruiting at 2 sites Phase 2 Tongji Hospital · Zhengzhou, Henan and 1 other locations · NCT07055581

• CT1190B CAR‑T therapy for relapsed or refractory B‑cell non‑Hodgkin lymphoma

  This trial will test CT1190B CAR‑T cell therapy in adults with relapsed or refractory B‑cell non‑Hodgkin lymphoma to see if it is safe and can shrink disease.

  Recruiting Phase 1 Tongji Hospital · Wuhang, Hubei · NCT07053670

• Tracking outcomes of uterine cavity conditions after hysteroscopy

  This project will follow adults with endometrial polyps, hyperplasia, or cancer who undergo hysteroscopy to see if detailed clinical and pathology data can predict disease course over one year.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07048327

• Ciprofol to reduce heart injury after VATS lung surgery

  This trial tests whether using ciprofol instead of propofol during general anesthesia for adults having VATS lung or mediastinal surgery can lower the chance of postoperative heart injury (MINS).

  Recruiting Phase 4 Tongji Hospital · Wuhan · NCT07028593

• Etomidate–propofol mixture versus propofol for anesthesia in older adults having abdominal surgery

  This trial will test whether mixing etomidate with propofol is safer than propofol alone for total intravenous anesthesia in older adults undergoing abdominal surgery.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07019246

• QL1706 and Bevacizumab as first-line treatment for advanced ovarian clear cell carcinoma

  This trial tests whether combining QL1706 with bevacizumab can give adults with newly diagnosed advanced ovarian clear cell carcinoma better outcomes than the standard platinum-based chemotherapy.

  Recruiting Phase 3 Tongji Hospital · Wuhan, Hubei · NCT07002346

• Using FOLFOX-HAIC to treat colorectal liver metastasis that can't be surgically removed

  This study is testing if a new combination of chemotherapy and targeted treatments can help people with colorectal cancer that has spread to the liver and can't be surgically removed, so they can eventually have surgery and live longer.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT06988852

• Combining Glumetinib and Fruquintinib for Advanced Colorectal Cancer

  This study is testing whether combining two drugs, Glumetinib and Fruquintinib, can help people with advanced colorectal cancer that hasn't responded to previous treatments.

  Recruiting Phase 1/2 Tongji Hospital · Wuhan, Hubei · NCT06980532

• Using Sanggua tablets to treat mild Type 2 diabetes and impaired glucose tolerance

  This study is testing if Sanggua tablets, a Traditional Chinese Medicine, can help people with mild Type 2 diabetes and high blood sugar levels feel better.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06964620

• Fluzoparib with bevacizumab or a low‑carb dietary plan versus fluzoparib alone as first‑line maintenance for HRD‑positive and HRD‑negative advanced ovarian cancer

  This trial tests whether adding bevacizumab or a low‑carb dietary plan to fluzoparib helps women with advanced ovarian cancer, with or without HRD, remain free of cancer longer after first‑line treatment.

  Recruiting at 2 sites Phase 3 Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06954584

• Neoadjuvant iparomlimab and tuvonralimab before surgery for resectable hepatocellular carcinoma

  This study tests whether giving iparomlimab and tuvonralimab before surgery, then after surgery, can help prevent cancer from coming back in people with resectable liver cancer at high risk of recurrence.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT06954116

• Understanding the connection between stroke and heart issues

  This study is trying to understand how strokes affect heart health and overall well-being in stroke patients to find new ways to help them recover better.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06954103

• Examining MRI Features to Improve Prostate Cancer Diagnosis

  This study is trying to see if special MRI pictures can help doctors better diagnose prostate cancer in men with high PSA levels or abnormal exams, aiming to reduce unnecessary biopsies and improve patient care.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06946771

• Glycerol phenylbutyrate for Chinese children and teens with urea cycle disorders

  This project will try glycerol phenylbutyrate in children and teens in China who have urea cycle disorders to see if it lowers ammonia and reduces hyperammonemic crises over five years.

  Recruiting at 5 sites Tongji Hospital · Beijing, Beijing Municipality and 4 other locations · NCT06904027

• CAR T-cell therapy for patients with relapsed or refractory lupus

  This study is testing a new CAR T-cell therapy to see if it can help people with lupus who haven't found relief from other treatments.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06902844

• New biomarkers for ischemic cerebrovascular disease

  This study will test whether specific blood, cerebrospinal fluid, urine, and stool biomarkers can help diagnose and predict outcomes for people with ischemic stroke and related cerebrovascular conditions.

  Recruiting Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06890702

• Monoclonal antibody treatments for AQP4-positive neuromyelitis optica spectrum disorder

  This registry will compare different monoclonal antibody therapies to see if they are safe and help adults in China who have AQP4-positive NMOSD.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06885957

• Angong Niuhuang pills with different bovine bezoar sources for acute ischemic stroke

  This will try two commercially made Angong Niuhuang pill formulations to see if they help adults with recent acute ischemic stroke recover better and reduce inflammation.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06883110

• Stem cell therapy for subacute intracerebral hemorrhage

  This study tests human umbilical cord mesenchymal stem cells given through the bloodstream to see if they are safe and helpful for people with a subacute intracerebral hemorrhage.

  Recruiting Phase 1/2 Tongji Hospital · Wuhan, Hubei · NCT06862388

• Developing a model to predict risks of iodine contrast medium extravasation

  This study is trying to create a tool to help doctors predict which patients might have problems with iodine contrast during CT scans, so they can manage the risks better.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06859242

• Evaluating VGN-R13 for treating ALS

  This study is testing a new gene therapy called VGN-R13 to see if it can safely help people with ALS feel better.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06849609

• Using manual acupuncture to lower uric acid levels in patients without symptoms

  This study is testing if manual acupuncture can help lower uric acid levels in people who have high uric acid but no symptoms.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06824376

• JY231 injection for treating difficult neurologic autoimmune disorders

  This study is testing if the JY231 injection can help people with tough-to-treat neurologic autoimmune disorders feel better and manage their symptoms.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06797024

• Treatment of relapsed/refractory multiple myeloma with ESO-T01

  This study is testing a new CAR T-cell therapy called ESO-T01 to see if it can help people with relapsed or refractory multiple myeloma feel better.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06791681

• High-MCT nutritional support for infants with biliary atresia

  We will test whether giving a high medium-chain triglyceride (MCT) formula before and after Kasai surgery helps infants with biliary atresia grow better and recover faster than standard feeding.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06764082

• Evaluating Peginterferon for treating Essential Thrombocythemia and Polycythemia Vera

  This study is testing if a weekly injection of Peginterferon can help people with Essential Thrombocythemia and Polycythemia Vera feel better and stay safe while using the treatment.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06734637

• Using mitomycin C before surgery to treat high-risk bladder cancer

  This study tests if giving mitomycin C before surgery can help people with high-risk bladder cancer stay cancer-free for a year compared to a placebo.

  Recruiting at 3 sites Phase 3 Tongji Hospital · Wuhan, Hubei and 2 other locations · NCT06696794

• JY231 injection for relapsed or refractory B‑cell lymphoma and leukemia

  This trial will test whether a single intravenous JY231 injection, given with or without short lymphodepletion, can help adults with relapsed or refractory CD19‑positive B‑cell lymphoma or B‑ALL.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06689917

• Evaluating Qifangfeixian Granules for Treating Lung Disease Related to Connective Tissue Disorders

  This study is testing if Qifangfeixian granules can help people with lung disease caused by connective tissue disorders feel better and improve their lung function.

  Recruiting Phase 2/3 Tongji Hospital · Wuhan, Hubei · NCT06674148

• Using mitochondrial DNA in blood to monitor biliary tract cancer recurrence

  This study is testing if checking for changes in mitochondrial DNA in blood can help doctors see if biliary tract cancer comes back after treatment.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06653127

• Using mitochondrial DNA in blood to monitor liver cancer recurrence

  This study is testing if looking at mitochondrial DNA in the blood can help doctors track liver cancer recurrence in patients after treatment.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06653062

• Improving ultrasonic image analysis with advanced algorithms

  This study is testing new computer programs to see if they can make ultrasound images clearer and help doctors better identify important features in those images.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06646679

• Evaluating NouvSoma001 for treating Neuromyelitis Optica Spectrum Disorders

  This study is testing a new treatment called NouvSoma001 to see if it can help people with Neuromyelitis Optica Spectrum Disorders feel better and stay safe while using it.

  Recruiting Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06620809

• Evaluating NouvSoma001 for treating ischemic stroke

  This study is testing a new treatment using special cells to see if it can help people recover better after having an ischemic stroke.

  Recruiting Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06612710

• Comparing two surgical methods for advanced gastric cancer after chemotherapy

  This study is testing whether a less extensive stomach surgery can help people with advanced gastric cancer live longer and feel better after chemotherapy compared to a more complete surgery.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06597227

• Using Calculus Bovis Sativus to treat adult encephalitis

  This study is testing a traditional Chinese medicine called Calculus Bovis Sativus to see if it can help adults with autoimmune encephalitis feel better.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06584045

• Using fospropofol for anesthesia in adult laparoscopic surgery

  This study is testing if a new anesthesia drug called fospropofol is safe and effective for adults having laparoscopic abdominal surgery, compared to the traditional drug propofol.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT06573489

• Using FRD001 to improve ultrasound imaging for ovarian cancer detection

  This study is testing if an injection called FRD001 can make ultrasound imaging better at telling the difference between harmless and cancerous ovarian growths in women.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06556342

• Evaluating KD01 for treating cervical cancer

  This study is testing a new treatment called KD01 for cervical cancer to see if it can safely target and kill cancer cells while being gentle on healthy tissue.

  Recruiting Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06552598

• Combination treatment for advanced colorectal cancer

  This study is testing a new combination of treatments for people with advanced colorectal cancer who haven't had success with previous therapies to see if it helps them live longer without their cancer getting worse.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06551207

• New method for detecting MicroRNA in breast cancer patients

  This study is testing a new way to detect MicroRNA in the blood of breast cancer patients to see if it can help track the disease and how well treatments are working.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06529614

• Observational study of immune status in chronic hepatitis B patients

  This study looks at the immune health of people with chronic hepatitis B to see how it varies in those who are untreated and those who have successfully lowered the virus with medication.

  Recruiting at 2 sites Tongji Hospital · Wuhan, Hubei and 4 other locations · NCT06525909

• Identifying biomarkers for autoimmune diseases affecting the nervous system

  This study is trying to find specific markers in the blood of people with autoimmune diseases affecting the nervous system, like Multiple Sclerosis, to help with early diagnosis and better treatment options.

  Recruiting Tongji Hospital · Wuhan · NCT06502015

• Preventive treatment for pneumonia in patients with autoimmune diseases

  This study is testing if a common antibiotic can help prevent a specific type of pneumonia in people with autoimmune diseases.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT06499233

• Evaluating PRG-1801 for treating difficult cases of Lupus Nephritis and IgG4-Related Disease

  This study is testing a new treatment called PRG-1801 to see if it can help adults with tough cases of Lupus Nephritis and IgG4-Related Disease feel better.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06497387

• Evaluating PRG-2311 for treating difficult cases of Lupus Nephritis and IgG4-Related Disease

  This study is testing a new treatment called PRG-2311 to see if it can help people with tough cases of Lupus Nephritis and IgG4-Related Disease improve their kidney function and overall health.

  Recruiting Early Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06497361

• Using Calculus Bovis Sativus to treat inflammatory demyelinating diseases

  This study is testing if a traditional Chinese medicine called Calculus Bovis Sativus can help people with conditions like multiple sclerosis feel better and reduce inflammation.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06474520

• Evaluating the effects of Calculus Bovis Sativus for ischemic cerebrovascular diseases

  This study is testing whether a traditional Chinese medicine called Calculus Bovis Sativus can help improve brain health and reduce inflammation in people with ischemic cerebrovascular diseases like stroke.

  Recruiting at 2 sites Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06474507

• Combining surgery with targeted and immunotherapy for advanced liver cancer

  This study is testing whether combining surgery with targeted therapy and immunotherapy can help people with advanced liver cancer live longer and feel better.

  Recruiting Phase 1 Tongji Hospital · Wuhan, Hubei · NCT06470256

• Using PET/MRI to Monitor Brain Inflammation

  This study is testing how PET/MRI scans can help track brain inflammation in people with conditions like stroke, autoimmune encephalitis, and multiple sclerosis.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06467773

• Rehabilitation for female pelvic floor dysfunction

  This study is testing different rehabilitation treatments for pelvic floor issues in Chinese women to see which ones work best for those with postpartum weakness and mild to moderate pelvic organ prolapse.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06461234

• Examining the link between blood microRNAs and Alzheimer's disease risk and severity

  This study is trying to see if certain tiny molecules in the blood can help us understand the risk and severity of Alzheimer's disease in both patients and healthy volunteers.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06442852

• Comparing spinal and general anesthesia for hip fracture surgery

  This study tests whether spinal anesthesia or general anesthesia leads to better breathing results after hip surgery in older patients who had to wait more than two days for their operation.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06425627

• Neoadjuvant therapy for patients with resectable hepatocellular carcinoma using deep learning.

  This study is testing a new treatment plan using a combination of chemotherapy and other medications for patients with early-stage liver cancer to see if it helps them live longer and reduces the chances of the cancer coming back after surgery.

  Recruiting at 2 sites Phase 2 Tongji Hospital · Xiangyang, Hubei and 1 other locations · NCT06420440

• Testing personalized therapy for advanced cancer patients with fluid buildup

  This study is testing if personalized cancer treatments based on patients' own tumor samples can help people with advanced cancers like lung and breast cancer feel better and improve their outcomes.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06413212

• Using Oliceridine for Pain Relief After Surgery

  This study is testing different doses of a new pain medication called oliceridine to see how well it helps people manage pain after upper abdominal surgery compared to morphine.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06409689

• Understanding chronic rhinitis in China

  This study is trying to learn more about chronic rhinitis by gathering information from 30,000 people in China to help improve treatments and prevention strategies.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06370468

• Opioid-free anesthesia for lung surgery

  This study is testing if using an opioid-free anesthesia approach during lung surgery helps patients recover better and have fewer complications.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06367218

• New MRI technology for assessing kidney dysfunction

  This study is testing a new MRI technology to see if it can safely and accurately check for kidney problems without the need for invasive procedures.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06366529

• Comparing triple and dual therapies after liver surgery for liver cancer

  This study is testing if a combination of three treatments after liver surgery can help people with liver cancer do better and have fewer chances of the cancer coming back compared to just using two treatments.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT06311942

• Targeted therapy after surgery for liver cancer

  This study is testing if a combination of two drugs can help patients with a specific type of liver cancer who are at high risk of their cancer coming back after surgery.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT06311929

• Using inhaled ICG to improve lung surgery in children

  This study is testing if inhaling a special dye before lung surgery can help doctors see better and improve outcomes for children with lung problems.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06302985

• Neoadjuvant chemoimmunotherapy and surgery for early-stage cervical cancer

  This study is testing if a new treatment combining chemotherapy and immunotherapy before surgery can help women with early-stage cervical cancer do better and have fewer complications.

  Recruiting at 2 sites Phase 2 Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06289751

• Neoadjuvant chemotherapy with Camrelizumab for early-stage cervical cancer

  This study is testing if a new combination of chemotherapy and a drug called Camrelizumab can help women with early-stage cervical cancer keep their fertility while aiming for complete remission.

  Recruiting at 2 sites Phase 2 Tongji Hospital · Guangzhou, Guangdong and 1 other locations · NCT06289062

• Comparing neoadjuvant chemoimmunotherapy and concurrent chemoradiotherapy for locally advanced cervical cancer

  This study is testing whether a new treatment combining chemoimmunotherapy and surgery can help people with locally advanced cervical cancer do better than the standard treatment of chemo and radiation.

  Recruiting at 12 sites Phase 2/3 Tongji Hospital · Hefei, Anhui and 11 other locations · NCT06288373

• Neoadjuvant immunochemotherapy for PD-L1-negative locally advanced cervical cancer

  This study is testing a new treatment that combines chemotherapy with a drug called Camrelizumab to see if it can help people with PD-L1-negative locally advanced cervical cancer before surgery.

  Recruiting at 12 sites Phase 2 Tongji Hospital · Hefei, Anhui and 11 other locations · NCT06288360

• Effect of Splenectomy on Treatment for Unresectable Liver Cancer

  This study is testing if removing the spleen can help improve treatment outcomes for patients with advanced liver cancer who also have cirrhosis by using a combination of targeted therapy and immunotherapy.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06280313

• CAR-T cell therapy for treating severe autoimmune diseases

  This study is testing a new CAR-T cell therapy to see if it can help people with severe autoimmune diseases like lupus nephritis and vasculitis who haven't found relief with other treatments.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06277427

• Effects of Sirolimus on Heart Disease in Patients with a Specific Virus

  This study is testing if the drug sirolimus can help improve heart health in patients with dilated cardiomyopathy who are also infected with a specific virus.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT06236022

• Treatment of Taxane-resistant Cancers with Paclitaxel Polymeric Micelles

  This study is testing a new form of chemotherapy called Paclitaxel Polymeric Micelles to see if it can help people with advanced cancers that didn't respond to standard Taxane treatments.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT06199895

• Combination therapy for patients with unresectable intrahepatic cholangiocarcinoma

  This study is testing a new combination of chemotherapy and targeted therapy to see if it can shrink tumors in patients with a type of liver cancer that can't be surgically removed.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT06192797

• Combination therapy for advanced liver cancer

  This study is testing a new combination of treatments for advanced liver cancer to see if it can shrink tumors enough to make them operable.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT06187961

• Combination treatment for advanced HR+/HER2- breast cancer

  This study is testing a new combination of treatments for people with advanced HR+/HER2- breast cancer to see if it can help them feel better after their previous treatments didn't work.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT06149130

• Evaluating the long-term effects of growth hormone treatment in children with short stature in China

  This study is testing the long-term effects of two types of growth hormone treatments to see how well they work and how safe they are for Chinese children with short stature.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06110910

• Immunotherapy using tumor-infiltrating lymphocytes for advanced liver cancer

  This study is testing a new treatment using patients' own immune cells to see if it can help people with advanced liver cancer who haven't had success with other therapies.

  Recruiting Phase 1 Tongji Hospital · Wuhan · NCT06084299

• Impact of Uterine Fibroids on Women's Fertility

  This study looks at how uterine fibroids might affect pregnancy rates in women aged 20-50 who are struggling with infertility.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06020924

• Uterine Fibroids in China: How Common They Are and What Increases Risk

  This study tests how common uterine fibroids are in Chinese women and what factors relate to developing them and needing surgery.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT05840042

• CABA artificial liver system for end-stage liver disease with inflammation

  This study tests a new artificial liver system called CABA (BS330 plus CA280) to help people with end-stage liver disease by filtering harmful substances and modulating inflammation.

  Recruiting Phase 4 Tongji Hospital · Wuhan, Hubei · NCT05780190

• Combining therapies for advanced liver cancer that can't be surgically removed

  This study is testing a new combination of treatments for patients with advanced liver cancer that can't be surgically removed to see if it helps them live longer and feel better than standard options.

  Recruiting at 2 sites Tongji Hospital · Quanzhou, Fujian and 1 other locations · NCT05713994

• Fecal microbiota transplantation for children with ulcerative colitis

  This study is testing if a treatment that combines fecal microbiota transplantation and special nutrition can help children with ulcerative colitis who haven't responded to regular treatments or those who are newly diagnosed.

  Recruiting Tongji Hospital · Wuhan · NCT05679622

• Using PET/CT imaging to evaluate estrogen receptors in breast cancer

  This study is testing a special type of imaging to see how well it can measure estrogen receptors in patients with breast cancer to help improve their treatment options.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT05541367

• Precision medicine for liver and biliary cancers using genetic testing

  This study is testing if personalized treatments based on genetic testing can help people with liver and bile duct cancers live longer and feel better.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT05520788

• New heart surgery technique for patients with hypertrophic obstructive cardiomyopathy

  This study is testing a new heart surgery technique for people with hypertrophic obstructive cardiomyopathy to see if it safely helps relieve their symptoms and improves their recovery.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT05332691

• Using fecal microbiota transplantation to treat active Crohn's disease in children

  This study is testing whether a new treatment using fecal microbiota transplantation along with a special diet can help children with newly diagnosed Crohn's disease feel better compared to a traditional treatment with medications.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT05321758

Showing recruiting studies first, then the newest. Describe your situation to find the ones that fit you.

Quick answers

How many clinical trials run by Tongji Hospital are recruiting right now?

160, as of November 12, 2026. 3 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 20, Phase 4: 15, Early Phase 1: 12, Phase 1: 11. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →